As of 4:00pm ET
| -2.63 / -1.53%|
The 22 analysts offering 12-month price forecasts for Allergan have a median target of 230.00, with a high estimate of 280.00 and a low estimate of 191.00. The median estimate represents a +35.90% increase from the last price of 169.24.
The current consensus among 26 polled investment analysts is to Buy stock in Allergan. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.